Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Royalty Pharma Adds to Management Team | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Royalty Pharma Adds to Management Team

Urist to serve as vice president of research and investments

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Marshall Urist, MD, Ph.D., has been named vice president of Research and Investments at Royalty Pharma. Dr. Urist joins the company from Morgan Stanley, where he spent the last eight years at in equity research, most recently as executive director and senior biotechnology analyst covering the life science tools and diagnostics sectors. 
 
“We are excited to have Marshall join our team. He has had a distinguished career on Wall Street, and this experience coupled with his deep analytical skills make him an excellent addition to Royalty Pharma,” said Pablo Legorreta, founder and chief executive officer of Royalty Pharma.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters